4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001794362-26-000004
Chief Financial Officer acquired 11,712 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tressler Nick B. Chief Financial Officer | 2026-06-30 | Grant or award | +11,712 | $0.19 | $2,250 | 11,712 | D |
Loading xslF345X06/form4-07022026_080720.xml…